中证网讯 通化东宝（600867 ）1月12日晚间发布公告，公司申报临床研究的门冬胰岛素注射液、门冬胰岛素原料药获得国家食品药品监督管理总局批准，收到了国家食品药品监督管理总局颁发的门冬胰岛素注射液...
Tonghua Dongbao (600867) January 12th evening announcement, the company to declare the clinical research Insulin Aspart Injection, insulin aspart API to obtain the State Administration of food and Drug Administration approval, received Insulin Aspart Injection issued by the State Administration of food and drug supervision and management...
